4550 Towne Centre Court | San Diego, California | 92121
October 23, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
Attention: C. Westbrook
| Re: | La Jolla Pharmaceutical Company (the “Company”) |
Registration Statement on FormS-3 |
FileNo. 333-227818 |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 PM (Eastern Time) on October 25, 2018, or as soon thereafter as is practicable.
Very truly yours,
La Jolla Pharmaceutical Company | ||
| By: | /s/ Dennis M. Mulroy | |
| Name: | Dennis M. Mulroy | |
| Title: | Chief Financial Officer | |